EU Court Clarifies Another SPC Conundrum
CJEU Judgement Brings Some Clarity But Raises More Questions
Can an SPC be awarded on the basis of a patent that does not give the actual name of the substance to be protected? A judgement from the EU's top court says it can, provided that a "skilled person" would be able to identify the substance from the functional claims in the patent.
You may also be interested in...
Early interaction with the European Medicines Agency is recommended if companies are planning to incorporate digital technologies into their drug development plans.
The latest global vaccines summit has seen the launch of a new mechanism designed to spur the development of new coronavirus vaccines and ensure they are made available, particularly in low- and middle-income countries.
Ambitious efforts to make the EU more resilient to future challenges, such as health threats, drug supply problems, scientific advances and growing medicine costs, have taken a step forward with the publication of a roadmap for a wide-ranging Pharmaceutical Strategy to be adopted by the European Commission later in the year.